Recent studies on osteoclast apoptosis and TGF-β gene regulation provide new insights into the mechanisms by which estrogens and their analogues inhibit bone resorption (pages 1132–1136).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Caputo, C.B., Meadows, D. & Raisz, L.G. Failure of estrogens and androgens to inhibit bone resorption in tissue culture. Endocrinology 98, 1065–1068 (1976).
Horowitz, M.C. Cytokines and estrogen in bone: Anti-osteoporotic effects. Science 260, 626–627 (1993).
Miyaura, C. et al. Endogenous bone resorbing factors and estrogen deficiency: Cooperative effects of IL-1 and IL-6. J. Bone Miner. Res. 10, 1365–1373 (1995).
Kawaguchi, H. et al. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J. Clin. Invest. 96, 539–548 (1995).
Kimble, R.B. et al. Simultaneous block of interleukin-1 and tumor necrosis factor is required to completely prevent bone loss in the early postovariectomy period. Endocrinology 136, 3054–3061 (1995).
Jilka, R.L. et al. Increased osteoclast development after estrogen loss: Mediation by interleukin-6. Science 257, 88–92 (1992).
Vargas, S. et al. Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow and marrow stromal cell cultures after ovariectomy. J. Bone Miner. Res. (in the press).
Hughes, D.E. et al. Estrogen promotes apoptosis of murine osteoclasts-mediated by TGF-β. Nature Med. 2, 1132–1136 (1996).
Pfeilschifter, J., Seyedin, S.M. & Mundy, G.R. Transforming growth factor-β inhibits bone resorption in fetal rat long bone cultures. J. Clin. Invest. 82, 680–685 (1988).
Oursler, M.J. et al. Modulation of transforming growth factor β production in normal human osteoblast-like cells by 17β-estradiol in parathyroid hormone. Endocrinology 129, 3313–3320 (1991).
Grainger, D.J. & Metcalfe, J.C. Tamoxifen: Teaching an old drug new tricks. Nature Med. 2, 381–385 (1996).
Draper, M.W. et al. A controlled trial of raloxifene (LY139481) HCl: Impact on bone turnover and serum lipid profile in healthy postmenopausal women. J. Bone Miner. Res. 11, 835–842 (1996).
Ke, H.Z. et al. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Bone 17, 491–496 (1995).
Yang, N.N. et al. Identification of an estrogen response element activated by metabolites and 17β-estradiol and raloxifene. Science 273, 1222–1224 (1996).
Raisz, L.G. The interaction of local and systemic factors in the pathogenesis of osteoporosis. in Osteoporosis. (eds. Marcus, R., Feldman, D., Kelsey, J.) 661–670 (Academic Press, San Diego, 1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Raisz, L. Estrogen and bone: New pieces to the puzzle. Nat Med 2, 1077–1078 (1996). https://doi.org/10.1038/nm1096-1077
Issue Date:
DOI: https://doi.org/10.1038/nm1096-1077
